12:00 - 13:00
Room: Pier 4

• Dr. Uzma Samadani, MD, PhD
  Rockswold Kaplan Endowed Chair for Traumatic Brain Injury Research
  Hennepin County Medical Center
  Associate Professor
  University of Minnesota Department of Neurosurgery

Overview:
There is ample evidence supporting the need for a better vital sign than intracranial pressure (ICP) for patients having endured a traumatic brain injury (TBI). Multiple prospective randomized trials have been completed (e.g. DECRA, EUROTHERM, RESCUEicp) that have raised more questions than answers about the current state of TBI management. The feasibility of utilizing a treatment protocol based on ICP and brain tissue oxygen (PbtO2) monitoring was evaluated in the BOOOST II trial, which was published in 2017. Results of this trial, as well as other data supporting the value of utilizing brain tissue oxygen monitoring for TBI management, will be reviewed and discussed.

7:30 - 8:20
Room: Pier 2+3

• Jan-Eric Ahlfors
  Inventor, CEO and CSO of Fortuna Fix
• Dr. Michael Fehlings
  Chairman of the SAB of Fortuna Fix
• Dr. Dallas Hack
  Member of the SAB of Fortuna Fix

About TEAM
TEAM is an organization established to promote international gender equality in neurotrauma research. It is an organization for all individuals interested in these aims regardless of gender. We appreciate a wide diversity of ideas and opinions to help the organization successfully meets its goals.

TEAM Lunch Symposium
On Monday, August 13th TEAM is hosting a Lunch SymposiumTalk Title: NINDS Strategies to Enhance Diversity of Neuroscience ResearchersSynopsis: The goal of session is to provide a summary of NINDS resources regarding diversity and to identify opportunities and share successful approaches for effective recruitment, training, and retention of diverse individuals within the neuroscience community.

Invited Speaker: Dr. Michelle D. Jones-London serves as chief in the Office of Programs to Enhance Neuroscience Workforce Diversity (OPEN) at the National Institute of Neurological Disorders and Stroke (NINDS), NIH. Jones-London provides leadership for the establishment of meaningful networks and partnerships to increase neuroscience workforce diversity by developing and implementing specific funding opportunities (individual and institutional) and works across the NINDS scientific portfolio to promote inclusion. She earned her PhD at Pennsylvania State University College of Medicine and then received postdoctoral training as a research fellow at University of Pennsylvania in the department of psychiatry. She has performed duties across the Department of Health and Human Services including the Center for Scientific Review, FDA Office of Women’s Health Science Program, and the Immediate Office of the Secretary, Intergovernmental/Tribal Affairs Office. Jones-London directs programs at NINDS which include Diversity and Re-Entry Supplements, Predoctoral Fellowships to Promote Diversity in Health-Related Research (F31), Career Development Awards to Promote Diversity (K22 and K01) and Diversity Research Education Grants (R25) (including the Neuroscience Scholars Program with SfN). Her trans-NIH efforts include oversight for the NIH Blueprint ENDURE program and D-SPAN (F99/K00).

Tickets are $20 and can be bought when registering for the symposium.

TEAM-VISA Award
The TEAM Neurotrauma (Training, Education and Mentoring) Visiting International Scholar Award (TEAM-VISA) was established to promote international networking opportunities and to advance the early careers of Neurotrauma researchers. The CAD 3,000 award provides an opportunity for international collaboration by subsidizing both travel to the NeuroTrauma 2018 Symposium in Toronto and a brief period of research training/collaboration in a sponsor’s laboratory. This award supports the mission of TEAM to promote international gender equality in neurotrauma research to learn new skills or techniques pertinent to their research projects.

TEAM-VISA AWARD Deadline: April 19, 2018

7:30 - 8:20
Room: Pier 2+3

• Jerome Badaut, Bordeaux, France
  Morpho-functional changes in neurovascular unit after juvenile mild-traumatic brain injury
  
• Inga Körte, Munich/Boston, Germany/USA
  Repetitive Subconcussive Head Impacts – Brain Alterations and Clinical Consequences (RepImpact)
• Juan M Encinas, Leioa, Spain
  Reactive Neurogenesis in the Hippocampus after Traumatic Brain Injury
• Nikolaus Plesnila, Munich, Germany
  Long-term histopathological and functional outcome after severe experimental TBI Speakers

13:00 - 14:00
Room: Harbour Ballroom A+B

• Michael G. Fehlings
  Introduction of the AOSpine Guidelines issue
• Brian Kwon
  Role and timing of surgical intervention including central cord injury
• Jeff Wilson
  Role of methylprednisolone
  
• Shekhar Kurpad
  Role of MR Imaging
  
• All Faculty
  Panel Discussion
• Michael G. Fehlings
  Closing Remark

• Kent Bassett-Spiers, CEO, Ontario Neurotrauma Foundation
• Michael Fehlings MD, PhD FRCSC, FACS Professor of Neurosurgery Vice Chair Research Department of Surgery Halbert Chair in Neural Repair and Regeneration
• Eve Tsai MD, PhD. Assistant Professor Neurosurgery Suruchi Bhargava Chair in Spinal Cord and Brain Regeneration Research
• Brain Kwon MD, PhD, FRCSC Professor of Orthopaedics, University of British Columbia. Associate Scientific Director Rick Hansen Institute
• Bill Barrable, CEO of Rick Hansen Institute